Heron Therapeutics, Inc. (LON:0J4V)

Heron Therapeutics Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Feb 20, 2025	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	208	200	247	687	1,408	1,598
Market Cap Growth	89.54%	-18.80%	-64.11%	-51.20%	-11.85%	0.63%
Enterprise Value	293	281	277	659	1,238	1,418
Last Close Price	1.39	1.34	2.11	7.51	15.35	12.81
PS Ratio	2.19	2.01	2.76	10.78	21.69	14.50
PB Ratio	-7.54	-7.51	21.90	12.00	8.13	5.24
P/TBV Ratio	-	-	21.90	12.00	8.13	5.24
EV/Sales Ratio	2.69	2.82	3.10	10.33	19.06	12.86
Debt / Equity Ratio	-4.46	-5.29	11.60	2.06	0.10	0.05
Asset Turnover	0.61	0.54	0.39	0.26	0.20	0.30
Inventory Turnover	1.65	2.42	3.07	3.89	6.27	7.16
Quick Ratio	1.61	1.76	1.66	2.72	2.44	4.46
Current Ratio	2.28	2.37	2.49	3.58	3.07	4.95
Return on Equity (ROE)	-	-	-399.43%	-140.53%	-70.99%	-52.91%
Return on Assets (ROA)	-2.31%	-24.56%	-38.01%	-41.04%	-32.11%	-27.01%
Return on Capital (ROIC)	-3.58%	-36.71%	-51.84%	-54.31%	-40.63%	-32.99%
Earnings Yield	-10.02%	-43.34%	-61.24%	-23.71%	-11.82%	-9.68%
FCF Yield	-3.45%	-23.65%	-50.04%	-22.17%	-9.97%	-6.22%
Buyback Yield / Dilution	-16.83%	-26.87%	-10.57%	-8.48%	-11.00%	-11.73%
Total Shareholder Return	-16.83%	-26.87%	-10.57%	-8.48%	-11.00%	-11.73%

Source: S&P Capital IQ. Standard template. Financial Sources.